Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Turning Point Therapeutics
Biotech
Geopolitics threatens Chinese biotechs' hot out-licensing biz
For the first time, China biotechs out-licensed more assets in 2023 than they in-licensed.
Max Bayer
Apr 11, 2024 4:00am
A new biotech blooms with $100M to take on small molecules
Feb 29, 2024 9:30am
BMS strikes up Roche rivalry with $4.1B Turning Point buy
Jun 3, 2022 9:01am
Lengo's hiring spree continues with Pfizer vet
Nov 1, 2021 9:30am
Turning Point posts data on Rozlytrek rival
Aug 20, 2020 9:15am
Top 10 biotech IPOs in 2019
Feb 24, 2020 9:00am